Shares of Bionano Genomics shot up in pre-market trading on Wednesday as the provider of genome analysis solutions announced that a study by Sorbonne Université indicated that whole genome sequencing (WGS) identified only 63% of the structural variations in liver cancer versus optical genome mapping (OGM). This study used a workflow that combined both OGM and WGS to maximize the detection of pathogenic variants and investigate complex rearrangements when it comes to liver cancer. This workflow also allowed researchers to compare OGM to WGS, and it indicated that OGM revealed a median of 1.4 times more structural variations than WGS.
https://www.tipranks.com/news/bionano-genomics-up-after-positive-ogm-study?utm_source=advfn.com&utm_medium=referral